Co-Diagnostics (CODX)

• Market cap: $6.02M
• 1 day: 7.05%
• 5 days: 15.17%
• 1 month: -35.52%
• 3 months: -48.46%
• 6 months: -83.9%
• Year to date: -69.96%
• 1 year: -84.33%
• 5 years: -99.32%
• 10 years: -99.04%
• Sector: Healthcare
• Industry: Medical Devices

About: Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Employees: 115